Venture Capital Firms Look To Vietnam For Health Care Growth
This article was originally published in PharmAsia News
Venture capitalists see Vietnam as a potentially lucrative venue for investments in health care. Analysts say national spending on health care in Vietnam is only 1.48 percent of gross domestic product, compared with 15.3 percent in the United States and 6 percent in neighboring Thailand. Several venture-capital firms already have committed funds to invest in Vietnam, including Viet Capital Fund Management, which has begun a health care fund with $31.25 million in capital. The fund's director believes the investment will encourage introduction of state-of-the-art diagnostic and treatment technology to Vietnam. (Click here for more
You may also be interested in...
Guardant’s CEO anticipates accelerated adoption and reimbursement of its FDA-approved liquid biopsy assay and more biopharma partnerships.
Public Company Edition: The German mRNA-focused company could raise up to $245m based on its proposed price range, but investor interest could drive the offering’s total higher. Also, Perceptive launches another SPAC, Regeneron sells $2bn in debt and Biohaven secures up to $950m.
Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.